App-Quantinova.ai

ADDITION OF INFLIXIMAB COMPARED WITH ADDITION OF SULFASALAZINE AND HYDROXYCHLOROQUINE TO METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS: 2-YEAR QUALITY OF LIFE RESULTS OF THE RANDOMISED, CONTROLLED SWEFOT TRIAL

J.A. Karlsson - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

NEUTROPHIL APOPTOSIS IS NOT AFFECTED BY GLUCOCORTICOID OR DMARD TREATMENT IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS - POSTER TOURS

F. Gohar - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Lupus

Hydroxychloroquine

STANDARDIZED INCIDENCE RATIOS (SIRS) AND RISK FACTORS OF SUICIDE IN CHINESE PATIENTS WITH RHEUMATIC DISEASES IN HONG KONG: 1999-2010

C.C. Mok - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

ADHERENCE TO SUBCUTANEOUS VS. ORAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS

M. Bergman - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

ANTI-TNF THERAPY IN SEVERE AND REFRACTORY SARCOIDOSIS: MULTICENTER STUDY OF 25 PATIENTS

I. Perez-Martin - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Septic shock

Hydroxychloroquine

THE CLINICAL OBSERVATIONAL STUDY OF ADULT ONSET STIL-S DISEASE IN A LARGE COHORT OF KOREAN PATIENTS

J.J. Kim - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Adult onset Still's disease

Hydroxychloroquine

MACROPHAGE ACTIVATION SYNDROME IN ADULT ONSET STIL-S DISEASE: A SINGLE CENTER EXPERIENCE

L.O. Damian - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Macrophage activation syndrome

Hydroxychloroquine

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS FOR RELAPSE IN KOREAN PATIENTS WITH POLYMYALGIA RHEUMATICA

J. Lee - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Giant cell arteritis

Hydroxychloroquine

RITUXIMAB CONVERTS PAEDIATRIC RHEUMATOID FACTOR POSITIVITY TO NEGATIVITY

E. Mosley - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Rheumatoid arthritis

Hydroxychloroquine

CASE REPORT: RAYNAU-S PHENOMENON WITH ORAL MANIFESTATION IN A CHILD PRESENTING MIXED CONNECTIVE TISSUE DISEASE

F. Bellutti Enders - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Raynaud syndrome

Hydroxychloroquine

PULMONARY ARTERIAL HYPERTENSION IN A FEMALE WITH JUVENILE-SLE

M. Rodrigues - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Pulmonary arterial hypertension

Hydroxychloroquine

REMISSION RATES INCREASE SUBSTANTIALLY BY ADDING ADALIMUMAB TO METHOTREXATE AND INTRA-ARTICULAR GLUCOCORTICOID IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS - 1-YEAR RESULTS OF INVESTIGATOR-INITIATED, DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL (OPERA)

K. Horslev-Petersen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Rheumatoid arthritis

Hydroxychloroquine

REMISSION AFTER ONE YEAR FOLLOW UP OF THE IMPROVED-STUDY, A RANDOMIZED CLINICAL TRIAL AIMING AT REMISSION IN PATIENTS WITH EARLY RHEUMATOID AND UNDIFFERENTIATED ARTHRITIS

L. Heimans - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

RISK FOR HERPES ZOSTER AFTER TREATMENT WITH BIOLOGIC AND SYNTHETIC DISEASE MODIFYING AGENTS FOR RHEUMATOID ARTHRITIS

D.A. Pappas - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Rheumatoid arthritis

Hydroxychloroquine

DIABETES IN RHEUMATOID ARTHRITIS: INCIDENCE AND ASSOCIATION WITH RA TREATMENT

M. Holmqvist - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Hydroxychloroquine

TIGHT CONTROL OF DISEASE ACTIVITY BY CONVENTIONAL DMARDS COULD MINIMIZE THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: DATA FROM AN EARLY ARTHRITIS CLINIC IN HONG KONG

C.H. To - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

DISPOSITIONAL OPTIMISM AND DEPRESSION SEVERITY IN EARLY ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND DMARD-COMBINATION THERAPY IN THE IMPROVED STUDY

L. Heimans - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

RHEUMATOID ARTHRITIS: WHAT ARE THE PREDICTORS OF RHEUMATOLOGIST-USUAL CAR- MANAGEMENT?

M.N. Lassere - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

USE OF DISEASE-MODIFYING TREATMENT (DMARD) IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL ASPECTS

N. Nikitina - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

TREAT TO TARGET EARLY RHEUMATOID ARTHRITIS CLINIC: HIGH RATES OF REMISSION AND LOW DISEASE ACTIVITY ON TREATMENT WITH CONVENTIONAL DISEASE MODIFYING DRUGS

O. Semenova - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Filters

1151 Abstracts